Annual CFI:
$52.59M+$184.09M(+140.00%)Summary
- As of today, BCRX annual cash from investing is $52.59 million, with the most recent change of +$184.09 million (+140.00%) on December 31, 2024.
- During the last 3 years, BCRX annual cash from investing has risen by +$36.79 million (+232.78%).
- BCRX annual cash from investing is now -32.52% below its all-time high of $77.93 million, reached on December 31, 2019.
Performance
BCRX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFI:
$29.13M+$2.03M(+7.50%)Summary
- As of today, BCRX quarterly cash from investing is $29.13 million, with the most recent change of +$2.03 million (+7.50%) on June 30, 2025.
- Over the past year, BCRX quarterly cash from investing has increased by +$31.58 million (+1289.34%).
- BCRX quarterly cash from investing is now -62.28% below its all-time high of $77.22 million, reached on December 31, 2022.
Performance
BCRX Quarterly Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$82.51M+$31.58M(+62.00%)Summary
- As of today, BCRX TTM cash from investing is $82.51 million, with the most recent change of +$31.58 million (+62.00%) on June 30, 2025.
- Over the past year, BCRX TTM cash from investing has increased by +$61.55 million (+293.78%).
- BCRX TTM cash from investing is now at all-time high.
Performance
BCRX TTM Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
BCRX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +140.0% | +1289.3% | +293.8% |
| 3Y3 Years | +232.8% | +129.9% | +159.2% |
| 5Y5 Years | -32.5% | +690.6% | +787.0% |
BCRX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +140.0% | -62.3% | +127.2% | at high | +138.1% |
| 5Y | 5-Year | -32.5% | +140.0% | -62.3% | +127.2% | at high | +138.1% |
| All-Time | All-Time | -32.5% | +140.0% | -62.3% | +127.2% | at high | +138.1% |
BCRX Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $29.13M(+7.5%) | $82.51M(+62.0%) |
| Mar 2025 | - | $27.09M(+52.2%) | $50.93M(-3.2%) |
| Dec 2024 | $52.59M(+140.0%) | $17.80M(+109.6%) | $52.59M(+731.8%) |
| Sep 2024 | - | $8.49M(+446.6%) | $6.32M(-69.8%) |
| Jun 2024 | - | -$2.45M(-108.5%) | $20.95M(+379.8%) |
| Mar 2024 | - | $28.76M(+201.0%) | $4.37M(+103.3%) |
| Dec 2023 | -$131.50M(-2.5%) | -$28.47M(-223.2%) | -$131.50M(-409.5%) |
| Sep 2023 | - | $23.12M(+221.5%) | -$25.81M(+78.2%) |
| Jun 2023 | - | -$19.04M(+82.2%) | -$118.47M(+39.8%) |
| Mar 2023 | - | -$107.11M(-238.7%) | -$196.88M(-53.5%) |
| Dec 2022 | -$128.24M(-911.4%) | $77.22M(+211.0%) | -$128.24M(+40.8%) |
| Sep 2022 | - | -$69.54M(+28.6%) | -$216.57M(-55.5%) |
| Jun 2022 | - | -$97.44M(-153.3%) | -$139.28M(-273.0%) |
| Mar 2022 | - | -$38.47M(-246.0%) | -$37.34M(-336.3%) |
| Dec 2021 | $15.80M(+330.5%) | -$11.12M(-243.5%) | $15.80M(-67.3%) |
| Sep 2021 | - | $7.75M(+72.0%) | $48.34M(+640.4%) |
| Jun 2021 | - | $4.50M(-69.3%) | $6.53M(+324.6%) |
| Mar 2021 | - | $14.67M(-31.5%) | -$2.91M(+57.6%) |
| Dec 2020 | -$6.86M(-108.8%) | $21.41M(+162.9%) | -$6.86M(+42.9%) |
| Sep 2020 | - | -$34.06M(-590.6%) | -$12.01M(-126.4%) |
| Jun 2020 | - | -$4.93M(-146.0%) | $45.57M(-37.4%) |
| Mar 2020 | - | $10.72M(-34.1%) | $72.78M(-6.6%) |
| Dec 2019 | $77.93M(+1534.5%) | $16.26M(-30.8%) | $77.93M(+33.2%) |
| Sep 2019 | - | $23.51M(+5.5%) | $58.51M(+129.7%) |
| Jun 2019 | - | $22.28M(+40.3%) | $25.47M(+439.3%) |
| Mar 2019 | - | $15.88M(+601.5%) | $4.72M(-1.0%) |
| Dec 2018 | $4.77M(+107.4%) | -$3.17M(+66.8%) | $4.77M(+109.6%) |
| Sep 2018 | - | -$9.53M(-721.3%) | -$49.45M(-30.3%) |
| Jun 2018 | - | $1.53M(-90.4%) | -$37.96M(+39.6%) |
| Mar 2018 | - | $15.93M(+127.8%) | -$62.85M(+2.8%) |
| Dec 2017 | -$64.64M(-377.8%) | -$57.38M(-3023.3%) | -$64.64M(-278.4%) |
| Sep 2017 | - | $1.96M(+108.4%) | -$17.09M(-688.9%) |
| Jun 2017 | - | -$23.35M(-265.2%) | $2.90M(-91.6%) |
| Mar 2017 | - | $14.13M(+243.8%) | $34.70M(+49.1%) |
| Dec 2016 | $23.27M(+229.3%) | -$9.83M(-144.8%) | $23.27M(-22.7%) |
| Sep 2016 | - | $21.95M(+159.9%) | $30.11M(+401.8%) |
| Jun 2016 | - | $8.44M(+211.9%) | -$9.98M(+12.1%) |
| Mar 2016 | - | $2.71M(+190.6%) | -$11.35M(+37.0%) |
| Dec 2015 | -$18.00M(+55.0%) | -$2.99M(+83.5%) | -$18.00M(+73.6%) |
| Sep 2015 | - | -$18.14M(-356.5%) | -$68.11M(-51.0%) |
| Jun 2015 | - | $7.07M(+279.1%) | -$45.10M(-5.1%) |
| Mar 2015 | - | -$3.95M(+92.6%) | -$42.91M(-7.3%) |
| Dec 2014 | -$39.98M(-1053.2%) | -$53.09M(-1191.2%) | -$39.98M(-468.6%) |
| Sep 2014 | - | $4.87M(-47.5%) | $10.85M(+6205.8%) |
| Jun 2014 | - | $9.27M(+1005.8%) | $172.00K(+102.6%) |
| Mar 2014 | - | -$1.02M(+54.8%) | -$6.56M(-89.3%) |
| Dec 2013 | -$3.47M(-113.9%) | -$2.26M(+61.1%) | -$3.47M(-242.0%) |
| Sep 2013 | - | -$5.81M(-329.4%) | $2.44M(-87.7%) |
| Jun 2013 | - | $2.53M(+22.2%) | $19.93M(+29.2%) |
| Mar 2013 | - | $2.07M(-43.2%) | $15.42M(-38.0%) |
| Dec 2012 | $24.88M(+119.9%) | $3.65M(-68.8%) | $24.88M(+34.2%) |
| Sep 2012 | - | $11.68M(+690.5%) | $18.55M(-20.1%) |
| Jun 2012 | - | -$1.98M(-117.1%) | $23.21M(+53.7%) |
| Mar 2012 | - | $11.54M(+528.7%) | $15.10M(+33.4%) |
| Dec 2011 | $11.32M(+5021.3%) | -$2.69M(-116.5%) | $11.32M(-48.9%) |
| Sep 2011 | - | $16.34M(+262.0%) | $22.13M(+83.6%) |
| Jun 2011 | - | -$10.09M(-230.0%) | $12.05M(-50.6%) |
| Mar 2011 | - | $7.76M(-4.5%) | $24.39M(>+9900.0%) |
| Dec 2010 | $221.00K(+101.7%) | $8.12M(+29.8%) | $221.00K(+100.5%) |
| Sep 2010 | - | $6.26M(+178.6%) | -$40.93M(-4.5%) |
| Jun 2010 | - | $2.25M(+113.7%) | -$39.15M(-21.4%) |
| Mar 2010 | - | -$16.41M(+50.3%) | -$32.24M(-150.0%) |
| Dec 2009 | -$12.89M | -$33.03M(-510.8%) | -$12.89M(-141.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | $8.04M(-12.2%) | $31.03M(+58.7%) |
| Jun 2009 | - | $9.16M(+212.3%) | $19.56M(+44.0%) |
| Mar 2009 | - | $2.93M(-73.1%) | $13.58M(+19.2%) |
| Dec 2008 | $11.39M(+175.8%) | $10.90M(+417.4%) | $11.39M(+223.0%) |
| Sep 2008 | - | -$3.44M(-208.0%) | $3.53M(+120.9%) |
| Jun 2008 | - | $3.18M(+326.4%) | -$16.92M(+23.7%) |
| Mar 2008 | - | $746.00K(-75.4%) | -$22.18M(-47.5%) |
| Dec 2007 | -$15.03M(-20.4%) | $3.04M(+112.7%) | -$15.03M(-127.4%) |
| Sep 2007 | - | -$23.88M(-1046.3%) | -$6.61M(-151.5%) |
| Jun 2007 | - | -$2.08M(-126.4%) | $12.83M(+26.6%) |
| Mar 2007 | - | $7.89M(-31.1%) | $10.13M(+181.1%) |
| Dec 2006 | -$12.49M(-8.5%) | $11.46M(+358.2%) | -$12.49M(+57.4%) |
| Sep 2006 | - | -$4.44M(+7.2%) | -$29.32M(-46.1%) |
| Jun 2006 | - | -$4.78M(+67.6%) | -$20.07M(+9.5%) |
| Mar 2006 | - | -$14.73M(-174.0%) | -$22.18M(-92.7%) |
| Dec 2005 | -$11.51M(-305.9%) | -$5.38M(-211.6%) | -$11.51M(-417.3%) |
| Sep 2005 | - | $4.82M(+169.9%) | -$2.23M(+66.3%) |
| Jun 2005 | - | -$6.89M(-69.7%) | -$6.62M(-3816.3%) |
| Mar 2005 | - | -$4.06M(-203.8%) | $178.00K(+106.3%) |
| Dec 2004 | -$2.84M(-133.9%) | $3.91M(+811.9%) | -$2.84M(+26.0%) |
| Sep 2004 | - | $429.00K(+524.8%) | -$3.84M(+12.7%) |
| Jun 2004 | - | -$101.00K(+98.6%) | -$4.39M(-626.9%) |
| Mar 2004 | - | -$7.08M(-342.9%) | $834.00K(-90.0%) |
| Dec 2003 | $8.37M(-18.5%) | $2.91M(+2358.1%) | $8.37M(+18.6%) |
| Sep 2003 | - | -$129.00K(-102.5%) | $7.06M(-23.6%) |
| Jun 2003 | - | $5.13M(+1019.4%) | $9.23M(+84.3%) |
| Mar 2003 | - | $458.00K(-71.4%) | $5.01M(-51.2%) |
| Dec 2002 | $10.26M(-49.6%) | $1.60M(-21.8%) | $10.26M(-9.8%) |
| Sep 2002 | - | $2.05M(+126.2%) | $11.38M(-11.2%) |
| Jun 2002 | - | $905.00K(-84.2%) | $12.80M(-18.6%) |
| Mar 2002 | - | $5.71M(+110.5%) | $15.72M(-22.9%) |
| Dec 2001 | $20.38M(+1292.6%) | $2.71M(-21.9%) | $20.38M(+7.1%) |
| Sep 2001 | - | $3.48M(-9.1%) | $19.03M(+10.6%) |
| Jun 2001 | - | $3.82M(-63.2%) | $17.20M(+23.3%) |
| Mar 2001 | - | $10.37M(+663.4%) | $13.95M(+853.0%) |
| Dec 2000 | $1.46M(+103.1%) | $1.36M(-17.4%) | $1.46M(+103.3%) |
| Sep 2000 | - | $1.64M(+186.4%) | -$44.09M(+1.2%) |
| Jun 2000 | - | $574.00K(+127.2%) | -$44.64M(+7.4%) |
| Mar 2000 | - | -$2.11M(+95.2%) | -$48.21M(-1.1%) |
| Dec 1999 | -$47.70M(-922.4%) | -$44.20M(-4118.2%) | -$47.70M(-622.7%) |
| Sep 1999 | - | $1.10M(+136.7%) | -$6.60M(-78.4%) |
| Jun 1999 | - | -$3.00M(-87.5%) | -$3.70M(-254.2%) |
| Mar 1999 | - | -$1.60M(+48.4%) | $2.40M(-58.6%) |
| Dec 1998 | $5.80M(-43.1%) | -$3.10M(-177.5%) | $5.80M(-42.0%) |
| Sep 1998 | - | $4.00M(+29.0%) | $10.00M(+6.4%) |
| Jun 1998 | - | $3.10M(+72.2%) | $9.40M(+2.2%) |
| Mar 1998 | - | $1.80M(+63.6%) | $9.20M(-9.8%) |
| Dec 1997 | $10.20M(+137.5%) | $1.10M(-67.6%) | $10.20M(+169.9%) |
| Sep 1997 | - | $3.40M(+17.2%) | -$14.60M(+3.3%) |
| Jun 1997 | - | $2.90M(+3.6%) | -$15.10M(+30.7%) |
| Mar 1997 | - | $2.80M(+111.8%) | -$21.80M(+19.9%) |
| Dec 1996 | -$27.20M(-1107.4%) | -$23.70M(-917.2%) | -$27.20M(-209.1%) |
| Sep 1996 | - | $2.90M(+176.3%) | -$8.80M(+22.8%) |
| Jun 1996 | - | -$3.80M(-46.2%) | -$11.40M(-418.2%) |
| Mar 1996 | - | -$2.60M(+50.9%) | -$2.20M(-181.5%) |
| Dec 1995 | $2.70M(+131.4%) | -$5.30M(-1866.7%) | $2.70M(-64.0%) |
| Sep 1995 | - | $300.00K(-94.4%) | $7.50M(-13.8%) |
| Jun 1995 | - | $5.40M(+134.8%) | $8.70M(+480.0%) |
| Mar 1995 | - | $2.30M(+560.0%) | $1.50M(+117.4%) |
| Dec 1994 | -$8.60M | -$500.00K(-133.3%) | -$8.60M(-6.2%) |
| Sep 1994 | - | $1.50M(+183.3%) | -$8.10M(+15.6%) |
| Jun 1994 | - | -$1.80M(+76.9%) | -$9.60M(-23.1%) |
| Mar 1994 | - | -$7.80M | -$7.80M |
FAQ
- What is BioCryst Pharmaceuticals, Inc. annual cash from investing?
- What is the all-time high annual cash from investing for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. annual cash from investing year-on-year change?
- What is BioCryst Pharmaceuticals, Inc. quarterly cash from investing?
- What is the all-time high quarterly cash from investing for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. quarterly cash from investing year-on-year change?
- What is BioCryst Pharmaceuticals, Inc. TTM cash from investing?
- What is the all-time high TTM cash from investing for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. TTM cash from investing year-on-year change?
What is BioCryst Pharmaceuticals, Inc. annual cash from investing?
The current annual cash from investing of BCRX is $52.59M
What is the all-time high annual cash from investing for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high annual cash from investing is $77.93M
What is BioCryst Pharmaceuticals, Inc. annual cash from investing year-on-year change?
Over the past year, BCRX annual cash from investing has changed by +$184.09M (+140.00%)
What is BioCryst Pharmaceuticals, Inc. quarterly cash from investing?
The current quarterly cash from investing of BCRX is $29.13M
What is the all-time high quarterly cash from investing for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high quarterly cash from investing is $77.22M
What is BioCryst Pharmaceuticals, Inc. quarterly cash from investing year-on-year change?
Over the past year, BCRX quarterly cash from investing has changed by +$31.58M (+1289.34%)
What is BioCryst Pharmaceuticals, Inc. TTM cash from investing?
The current TTM cash from investing of BCRX is $82.51M
What is the all-time high TTM cash from investing for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high TTM cash from investing is $82.51M
What is BioCryst Pharmaceuticals, Inc. TTM cash from investing year-on-year change?
Over the past year, BCRX TTM cash from investing has changed by +$61.55M (+293.78%)